GETI.B

213.8

+0.38%↑

CAMX

607.5

+0.08%↑

BIOAB

321.6

+1.2%↑

EKTA.B

56.2

-0.18%↓

AMBEA

141.3

-0.07%↓

GETI.B

213.8

+0.38%↑

CAMX

607.5

+0.08%↑

BIOAB

321.6

+1.2%↑

EKTA.B

56.2

-0.18%↓

AMBEA

141.3

-0.07%↓

GETI.B

213.8

+0.38%↑

CAMX

607.5

+0.08%↑

BIOAB

321.6

+1.2%↑

EKTA.B

56.2

-0.18%↓

AMBEA

141.3

-0.07%↓

GETI.B

213.8

+0.38%↑

CAMX

607.5

+0.08%↑

BIOAB

321.6

+1.2%↑

EKTA.B

56.2

-0.18%↓

AMBEA

141.3

-0.07%↓

GETI.B

213.8

+0.38%↑

CAMX

607.5

+0.08%↑

BIOAB

321.6

+1.2%↑

EKTA.B

56.2

-0.18%↓

AMBEA

141.3

-0.07%↓

Kodu・Aktsiate loetelu・Vitrolife AB

V
Vitrolife AB

Avatud

137.7 -0.22

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

135.3

Max

139.1

Põhinäitajad
By Trading Economics
Sissetulek	-30M 102M
Müük	-36M 835M
P/E Sektori keskmine	41.539 76.798
Aktsiakasum	0.753
Dividenditootlus	0.79
Kasumimarginaal	12.216
Töötajad	1,100
EBITDA	118M 255M

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	0.79% 2.37%
Järgmine tulemuste avaldamine	3. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	-1.5B 18B
Eelmine avamishind	137.92
Eelmine sulgemishind	137.7

Vitrolife AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. dets 2025, 23:54 UTC

Suurimad hinnamuutused turgudel

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22. dets 2025, 19:08 UTC

Omandamised, ülevõtmised, äriostud

Correction to Alphabet to Buy Intersect Article

22. dets 2025, 17:21 UTC

Omandamised, ülevõtmised, äriostud

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22. dets 2025, 16:46 UTC

Omandamised, ülevõtmised, äriostud

Alphabet to Buy Intersect for $4.75 Billion in Cash

22. dets 2025, 23:50 UTC

Market Talk

Nikkei May Decline as Yen Rebounds -- Market Talk

22. dets 2025, 23:42 UTC

Market Talk

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22. dets 2025, 22:31 UTC

Tulu

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22. dets 2025, 22:31 UTC

Tulu

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22. dets 2025, 22:30 UTC

Tulu

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. dets 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

22. dets 2025, 21:37 UTC

Omandamised, ülevõtmised, äriostud

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22. dets 2025, 21:36 UTC

Omandamised, ülevõtmised, äriostud

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22. dets 2025, 21:35 UTC

Omandamised, ülevõtmised, äriostud

Capricorn to Acquire Prospective Package From Tempest Minerals

22. dets 2025, 21:35 UTC

Omandamised, ülevõtmised, äriostud

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22. dets 2025, 20:54 UTC

Omandamised, ülevõtmised, äriostud

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22. dets 2025, 20:52 UTC

Omandamised, ülevõtmised, äriostud

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22. dets 2025, 20:09 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22. dets 2025, 19:56 UTC

Market Talk

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22. dets 2025, 19:49 UTC

Omandamised, ülevõtmised, äriostud

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22. dets 2025, 19:23 UTC

Market Talk

Mexico's Inflation Seen Easing in Early December -- Market Talk

22. dets 2025, 19:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. dets 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

22. dets 2025, 19:02 UTC

Market Talk

Precious Metals Climb to New Heights -- Market Talk

22. dets 2025, 18:45 UTC

Market Talk

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22. dets 2025, 18:30 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22. dets 2025, 18:23 UTC

Omandamised, ülevõtmised, äriostud

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22. dets 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

22. dets 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

22. dets 2025, 17:06 UTC

Omandamised, ülevõtmised, äriostud

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Võrdlus sarnastega

Hinnamuutus

Vitrolife AB Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.